Abstract:Objective To investigate the clinical effect of hyperbaric oxygen in the treatment of neonatal hypoxic ischemic encephalopathy.Methods Between January 2013 and February 2017, 130 cases of neonatal hypoxic ischemic encephalopathy were selected as subjects, who were randomly divided into control group and observation group with 65 cases in each. The control group was given routine symptomatic treatment, while the observation group was additionally given hyperbaric oxygen therapy. Both groups were observed for three months.Results After treatment, the total effective rates in the observation group and the control group were 98.5% and 81.5%, respectively.After treatment, the MMSE scores in the observation group and the control group were 89.45±5.39 points and 78.20±6.14 points, compared with 65.23±8.14 points and 65.11±7.89 points before treatment (P<0.05).The levels of serum CK, LDH and CK were significantly lower after treatment in the two groups (P<0.05), and the indexes in the observation group were significantly lower after treatment than those in the control group (P<0.05).The NOX2 gray ratio and ROS in the two groups were significantly lower after treatment.The NOX2 gray ratio (0.37±0.06) in the observation group was significantly lower after treatment than in the control group (0.42±0.09) (P<0.05). ROS (518.85±54.48) U/ml in the observation group was also significantly lower than in the control group (551.28±69.93) U/ml (P<0.05).Conclusions Hyperbaric oxygen, when used in the treatment of neonatal hypoxic ischemic encephalopathy, can improve myocardial function while inhibiting oxidative stress, thus improving the therapeutic effect and promoting cognitive function, so it has good applicability.
李娜, 吕艳, 孟祥恩, 郭大志, 潘树义. 高压氧舱治疗新生儿缺氧缺血性脑病的疗效探讨[J]. 武警医学, 2018, 29(3): 282-286.
LI Na, LV Yan, MENG Xiangen, GUO Dazhi, PAN Shuyi. The clinical study of hyperbaric oxygen in the treatment of neonatal hypoxic ischemic encephalopathy. Med. J. Chin. Peop. Armed Poli. Forc., 2018, 29(3): 282-286.
Neves A L, Henriques-Coelho T, Leite-Moreira A, et al.Cardiac injury biomarkers in paediatric age: Are we there yet?[J].Heart Fail Rev,2016,21(6):771-781.
[2]
Bhorat I E, Bagratee J S, Pillay M, et al.Determination of the myocardial performance index in deteriorating grades of intrauterine growth restriction and its link to adverse outcomes[J].Prenat Diagn,2015 ,35(3):266-273.
Hochwald O, Jabr M, Osiovich H, et al.Preferential cephalic redistribution of left ventricular cardiac output during therapeutic hypothermia for perinatal hypoxic-ischemic encephalopathy[J].J Pediatr,2014,164(5):999-1004.
[5]
Montaldo P, Rosso R, Chello G, et al.Cardiac troponin I concentrations as a marker of neurodevelopmental outcome at 18 months in newborns with perinatal asphyxia[J].J Perinatol,2014,34(4):292-295.
[6]
Ameri K, Rajah A M, Nguyen V, et al.Nuclear localization of the mitochondrial factor HIGD1A during metabolic stress[J].PLoS One,2013,8(4):e62758.
[7]
Simovic A M, Igrutinovic Z, Obradovic S, et al.The significance of second generation cardiac troponin I in early screening of hypoxic-ischemic encephalopathy after perinatal asphyxia[J].Srp Arh Celok Lek,2012,140(9-10):600-605.
Robertson N J, Kato T, Bainbridge A, et al.Methyl-isobutyl amiloride reduces brain Lac/NAA, cell death and microglial activation in a perinatal asphyxia model[J].J Neurochem,2013,124(5):645-657.
[10]
Vijlbrief D C, Benders M J, Kemperman H, et al.Cardiac biomarkers as indicators of hemodynamic adaptation during postasphyxial hypothermia treatment[J].Neonatology,2012,102(4):243-248.
Mirza M A, Ritzel R, Xu Y, et al.Sexually dimorphic outcomes and inflammatory responses in hypoxic-ischemic encephalopathy[J].Journal of Neuroinflammation,2015,12(1):1121-1130.
Li Y, Zhang P, Liu Y, et al.Helium preconditioning protects the brain against hypoxia/ischemia injury via improving the neurovascular niche in a neonatal rat model[J].Behav Brain Res,2016,1(314):165-172.
[15]
Chen J, Chen Y H, Lv H Y, et al.Effect of hyperbaric oxygen on lipid peroxidation and visual development in neonatal rats with hypoxia-ischemia brain damage[J].Biomed Rep,2016,5(1):136-140.
[16]
Kidani Y, Miki Y, Nomimura N, et al.The therapeutic effect of CD133 +, cells derived from human umbilical cord blood on neonatal mouse hypoxic-ischemic encephalopathy model[J].Life Sciences, 2016, 157(45):108-115.
[17]
Aggarwal S, Natarajan G.Biventricular function on early echocardiograms in neonatal hypoxic-ischaemic encephalopathy[J].Acta Paediatr,2017,106(7):1085-1090.
[18]
Nestaas E, Skranes J H, Støylen A, et al.The myocardial function during and after whole-body therapeutic hypothermia for hypoxic-ischemic encephalopathy, a cohort study[J].Early Hum Dev,2014,90(5):247-252.
Ostrowski R P, Stepień K, Pucko E, et al.Hyperbaric oxygen modalities are differentially effective in distinct brain ischemia models[J].Med Gas Res,2016,6(1):39-47.
[21]
Gamdzyk M, Ziembowicz A, Bratek E, et al.Combining hypobaric hypoxia or hyperbaric oxygen postconditioning with memantine reduces neuroprotection in 7-day-old rat hypoxia-ischemia[J].Pharmacol Rep,2016,68(5):1076-1083.
[22]
Li Y, Liu K, Kang Z M, et al.Helium preconditioning protects against neonatal hypoxia-ischemia via nitric oxide mediated up-regulation of antioxidases in a rat model[J].Behav Brain Res,2016,1(300):31-37.
[23]
Zhu M, Lu M, Li Q J, et al.Hyperbaric oxygen suppresses hypoxic-ischemic brain damage in newborn rats[J].J Child Neurol,2015,30(1):75-82.
Stetler R A, Leak R K, Gan Y, et al.Preconditioning provides neuroprotection in models of CNS disease:paradigms and clinical significance[J].Prog Neurobiol,2014,3(114):58-83.
[26]
Feng Z, Liu J, Ju R.Hyperbaric oxygen treatment promotes neural stem cell proliferation in the subventricular zone of neonatal rats with hypoxic-ischemic brain damage[J].Neural Regen Res,2013,8(13):1220-1227.
Liu X H, Yan H, Xu M, et al.Hyperbaric oxygenation reduces long-term brain injury and ameliorates behavioral function by suppression of apoptosis in a rat model of neonatal hypoxia-ischemia[J].Neurochem Int,2013,62(7):922-930.
[29]
Lobo N, Yang B, Rizvi M, et al.Hypothermia and xenon: novel noble guardians in hypoxic-ischemic encephalopathy?[J].J Neurosci Res,2013,91(4):473-478.